DRMA

0.50954.23%
DF

David F. Hale

Co-Founder & Lead Independent Director

Mr. David F. Hale is Founder of Dermata Therapeutics, Inc. and served as its Managing Director. Mr. Hale serves as Advisor at Windamere Venture Partners, LLC. Mr. Hale served as Interim President & Chief Executive Officer at Zerigo Health, Inc. (formerly known as Clarify Medical, Inc.). since March 2020 until June 2020. He is a co-Founder and had been an Independent Director of the Oncternal Therapeutics, Inc. Board since June 2019 until July 2025 and was its Independent Chairman since June 2019 until July 2025. Mr. Hale has been the Lead Director of Dermata Therapeutics, Inc. since April 2021 and has been its Independent Director since December 2014. He is a co-Founder of CONNECT. Since May 2006, he serves as the Chairman and Chief Executive Officer at Hale BioPharma Ventures, LLC. He is Co-Founder of Neurelis Pharmaceuticals, Inc. and served as its Chairman and Chief Executive Officer. He co-founded Pernix Sleep, Inc. in August 2003 and served as its Interim Chief Executive Officer from January 2008 to August 2008 and Executive Chairman since August 2003. He served as Principal Executive Officer of Biocept, Inc. until August 26, 2013. In 1982, after joining Hybritech, Inc., the first monoclonal antibody company, he served as the Chief Operating Officer, President and then Chief Executive Officer in 1986, when Hybritech was acquired by Eli Lilly and Co. in 1986. From 1987 to 1997, he was Chairman, President and Chief Executive Officer of Gensia, Inc. and a co-Founder and Chairman of Viagene, Inc. from 1987 to 1995. Prior to joining Hybritech, he served as Vice President and General Manager of BBL Microbiology Systems, a diagnostics division of Becton, Dickinson & Co. and from 1971 to 1980, held various marketing and sales management positions with Ortho Pharmaceutical Corporation, a division of Johnson & Johnson, Inc. He served as Chief Executive Officer and President at CancerVax Corp. from October 2000 until its merger in May 2006 with Micromet, Inc., when he became Chairman until 2012. He served as Executive Chairman and Acting Principal Executive Officer of Metabasis Therapeutics, Inc. since September 1, 2009 and October 30, 2009 respectively. He serves as Chairman at Ridge Diagnostics, Inc., The Board at CRISI Medical Systems, Inc., Advantar Laboratories, Inc., Intrepid Therapeutics, Inc., Katama Pharmaceuticals, Skylit Medical and served as Chairman of CRISIMed, Inc., Agility Clinical, Inc. He had been the Chairman of Conatus Pharmaceuticals Inc. since December 2012 and had been its Director since October 2006. He had been a Non-Executive Independent Chairman of the Board at Biocept, Inc. since February 10, 2014 until 2020 and served as its Executive Chairman from March 2011 to February 10, 2014 and served as Director since 2020 until 2022. He also serves as Chairman of the Board of Trustees of Rady Children’s Hospital. He was a co-founder and served as a member of the board of directors of Private Oncternal since 2013 and Chairman of the Board of Private Oncternal from December 2018 until the Merger. Mr. Hale served as Chairman of Santarus, Inc. from February 2004 to January 2, 2014 and served as its Director from June 2000 to January 2, 2014. He is a co-founder of the CONNECT Program in Technology and Entrepreneurship. Mr. Hale also is a co-founder and serves on the Board of Directors of BIOCOM, is a former member of the board of The Biotechnology Industry Organization or BIO and the San Diego Economic Development Corporation. He served as the Executive Chairman of SkinMedica, Inc. from March 2003 to 2012 and served as its Director from 2001 to 2012. He served as Chairman of Metabasis Therapeutics, Inc. since September 14, 2006 and served as its Independent Director since April 1997. He was Chairman at Adigica Health, Inc. He served as Chairman of Micromet, Inc. from May 2006 to March 2, 2012. He served as Chairman of Colorescience, Inc. He serves as a Director of CONNECT. He serves as Trustee at Sanford Burnham Prebys Medical Discovery Institute (formerly, Sanford-Burnham Medical Research Institute). He serves as Director at Biotechnology Institute, The. Mr. Hale also serves as a member of the board of directors of the San Diego Economic Development Corporation. He serves as Director of Verus Pharmaceuticals, Inc. and Adigica Health, Inc. He serves as a Director of Neurelis Pharmaceuticals, Inc. Mr Halse is a co-founder of Cadence Inc., Evoke Pharma Inc., Elevation Pharmaceutical Incorporated and Zogenix Incorporated. Mr. Hale served as a Non-Executive Independent Director of Cassiopea S.p.A. since April 2015 until October 24, 2017. He served as a Director of Tokalas, Inc. He served as Director of Dura Pharmaceuticals, Inc. since 1986. He served as Director at CancerVax Corp. since December 2000, Xcel Pharmaceuticals Inc. since November 2001 and Micromet, Inc. from December 2000 to March 7, 2012. Mr. Hale received a Bachelor of Arts degree in Biology and Chemistry from Jacksonville State University. He is a co-Founder and served as Chairman of Somaxon Pharmaceuticals, Inc. before its acquisition by Pernix Therapeutics Holdings, Inc. He served as Executive Chairman of Zerigo Health, Inc. (formerly known as Clarify Medical, Inc.). He also serves as Chairman of MDRejuvena, Inc., Neurana Pharmaceuticals, Inc. and Recros Medica, Inc. He was President and Chief Executive Officer of Women First HealthCare, Inc. from January 1998 to June 2000, before joining CancerVax in October 1999.

公司職務